Date: 2014-07-23 09:04:29

Angiology

Vascular endothelial growth factor

Diabetic retinopathy

Macular edema

Ranibizumab

Macular degeneration

Retina

Regeneron

Eye disease

Ophthalmology

Vision

Medicine

iCo Therapeutics July 1, 2014 Andrew Rae, President & CEO[removed]www.icotherapeutics.com / TSX-V: ICO

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 2,77 MB